Zhang Elaine, Zhao Teresa, Sikora Tim, Ellaway Carolyn, Gold Wendy A, Van Bergen Nicole J, Stroud David A, Christodoulou John, Kaur Simranpreet
Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia.
Murdoch Children's Research Institute, Royal Children's Hospital, Melbourne, Victoria, Australia.
Hum Mutat. 2025 Jun 2;2025:5485987. doi: 10.1155/humu/5485987. eCollection 2025.
Rett syndrome (RTT) is a rare, X-linked, severe neurodevelopmental disorder, predominantly associated with pathogenic variants in the methyl-CpG-binding protein-2 () gene, with an increasing number of atypical RTT or RTT-like individuals having pathogenic variants in other genes, such as cyclin-dependent kinase-like 5 () or forkhead box G1 (). However, ~20% of individuals with a clinical diagnosis of RTT remain genetically undiagnosed, highlighting the importance of ongoing genomic and functional studies to expand the genetic spectrum of RTT. We present a female who was born to healthy nonconsanguineous parents and presented with severe intellectual disability, macrocephaly, ataxia, absent speech, and poor eye contact. The affected individual was clinically diagnosed with atypical RTT, but genetic testing showed no pathogenic variants in , , or Singleton whole genome sequencing was conducted, which identified a heterozygous stop-gain variant [NM_001170629.2: c.5017C>T, p.(Arg1673)], in the chromodomain-helicase-DNA-binding protein 8 () gene. Variant curation revealed its absence in unaffected populations, in silico predictions of pathogenicity, and an existing association with () (OMIM #615032). In vitro functional analyses, including Western blots, quantitative reverse transcription polymerase chain reaction (qRT-PCR), and proteomic analyses, demonstrated a significant reduction of the CHD8 transcript and two CHD8 protein isoforms in the proband's skin fibroblasts relative to control fibroblasts. Additionally, proteomic analysis indicated a significant reduction of the MeCP2 protein, indicating a possible molecular link between CHD8 and MeCP2 and thus clinically between IDDAM and RTT. As the affected individual's phenotype is consistent with atypical RTT, our results suggest that could be considered in the expanding genetic spectrum of atypical RTT, which may assist the diagnosis of other -negative RTT individuals.
雷特综合征(RTT)是一种罕见的、X连锁的严重神经发育障碍,主要与甲基CpG结合蛋白2(MECP2)基因的致病变异相关,越来越多的非典型RTT或RTT样个体在其他基因中存在致病变异,如细胞周期蛋白依赖性激酶样5(CDKL5)或叉头框G1(FOXG1)。然而,约20%临床诊断为RTT的个体在基因上仍未得到诊断,这凸显了持续进行基因组和功能研究以扩大RTT基因谱的重要性。我们报告一名女性,其父母健康且非近亲结婚,该女性表现出严重智力残疾、巨头畸形、共济失调、无语言能力以及眼神交流差。该受影响个体临床诊断为非典型RTT,但基因检测显示MECP2、CDKL5或FOXG1中没有致病变异。进行了单例全基因组测序,在染色质结构域解旋酶DNA结合蛋白8(CHD8)基因中鉴定出一个杂合的终止密码子获得变异[NM_001170629.2: c.5017C>T, p.(Arg1673)]。变异评估显示该变异在未受影响人群中不存在,通过计算机模拟预测其致病性,并且与IDDC(OMIM #615032)存在现有关联。体外功能分析,包括蛋白质免疫印迹、定量逆转录聚合酶链反应(qRT-PCR)和蛋白质组学分析,结果表明,与对照成纤维细胞相比,先证者皮肤成纤维细胞中CHD8转录本和两种CHD8蛋白异构体显著减少。此外,蛋白质组学分析表明MeCP2蛋白显著减少,这表明CHD8与MeCP2之间可能存在分子联系,从而在临床上提示IDDC与RTT之间的联系。由于受影响个体的表型与非典型RTT一致,我们的结果表明,在不断扩大的非典型RTT基因谱中可考虑CHD8,这可能有助于诊断其他MECP2阴性的RTT个体。